MBLAC1: A Protein That Regulates T-cells and Immune System (G255374)

Target Name: MBLAC1

NCBI ID: G255374

MBLAC1

MBLAC1: A Protein That Regulates T-cells and Immune System

MBLAC1 (MBLAC1_HUMAN) is a protein that is expressed in various tissues of the human body. It is a member of the CD28 superfamily and is located in the T-cell receptor alpha chain subfamily. MBLAC1 plays a crucial role in the development and regulation of T-cells, which are a vital part of the immune system.

One of the most significant functions of MBLAC1 is its role in the regulation of T-cell proliferation. T-cells are a vital part of the immune system and play a critical role in protecting the body against infection and disease. MBLAC1 helps to regulate the growth and differentiation of T-cells, which are essential for their function.

Another important function of MBLAC1 is its role in the regulation of T-cell death. T-cells have a limited lifespan and are often killed by factors such as exposure to radiation or chemotherapy. MBLAC1 helps to regulate T-cell death by promoting the production of a protein called apoptosis-associated homeostasis (APAS), which helps to ensure that T-cells are properly programmed to die.

MBLAC1 is also involved in the regulation of T-cell receptor (TCR) function. TCR is a critical receptor that is expressed on T-cells and plays a crucial role in recognizing and responding to foreign antigens. MBLAC1 helps to regulate TCR function by interacting with the TCR and influencing the structure and function of the TCR.

In addition to its role in T-cell regulation, MBLAC1 is also involved in the regulation of inflammation. T-cells are a key source of inflammation in the body and play a critical role in fighting off infections and diseases. MBLAC1 helps to regulate inflammation by promoting the production of pro-inflammatory cytokines, which help to recruit and activate T-cells.

MBLAC1 is also involved in the regulation of the immune response. T-cells are a critical part of the immune system and play a vital role in protecting the body against infection and disease. MBLAC1 helps to regulate the immune response by promoting the production of T-cells, which are essential for the immune response.

In conclusion, MBLAC1 (MBLAC1_HUMAN) is a protein that is expressed in various tissues of the human body. It is a member of the CD28 superfamily and is located in the T-cell receptor alpha chain subfamily. MBLAC1 plays a crucial role in the development and regulation of T-cells, which are a vital part of the immune system. It is also involved in the regulation of T-cell proliferation, T-cell death, TCR function, inflammation, and the immune response. Therefore, MBLAC1 is a potential drug target and a biomarker for various diseases.

Protein Name: Metallo-beta-lactamase Domain Containing 1

Functions: Endoribonuclease that catalyzes the hydrolysis of histone-coding pre-mRNA 3'-end. Involved in histone pre-mRNA processing during the S-phase of the cell cycle, which is required for entering/progressing through S-phase (PubMed:30507380). Cleaves histone pre-mRNA at a major and a minor cleavage site after the 5'-ACCCA-3' and the 5'-ACCCACA-3' sequence, respectively, and located downstream of the stem-loop (PubMed:30507380). May require the presence of the HDE element located at the histone pre-RNA 3'-end to avoid non-specific cleavage (PubMed:30507380)

The "MBLAC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MBLAC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets